​

Funding Round

Series A - Caribou Biosciences

Series A - Caribou Biosciences

Investment Firm

Overview

Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.

Announced Date

Mar 25, 2015

Closed on Date

Apr 22, 2015

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Genoa Ventures

Genoa Ventures

Genoa Ventures is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorJennifer Doudna
Participant InvestorMission Bay Capital
Participant InvestorThe Howard Hughes Medical Institute
Participant InvestorF-Prime Capital
Participant InvestorNovartis

Round Details and Background

Caribou Biosciences raised $11000000 on 2015-03-25 in Series A

Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 13, 2023
Post-IPO Equity - Caribou Biosciences
-125.0M
May 16, 2016
Series B - Caribou Biosciences
9-30.0M
Mar 25, 2015
Series A - Caribou Biosciences
7-11.0M
Sep 22, 2014
Venture Round - Caribou Biosciences
1-11.5M

Recent Activity

There is no recent news or activity for this profile.